Download PDF
Open Access
CC BY-NC-ND 4.0 · South Asian J Cancer 2013; 02(04): 259
DOI: 10.4103/2278-330X.119889
PEDIATRIC SECTION: Editorial

Chronic myeloid leukemia in India: The poster child of translational medicine needs help!

Authors

  • Vishal Jayakar

    Department of Haematology, Kingston NHS Trust and Royal Marsden Hospital, St. George’s Medical School, London, UK

Source of Support: Nill.
Further Information
Also available at
 PDF Download Permissions and Reprints
Preview Container


Publication History

Article published online:
31 December 2020

© 2013. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Raut SL, Bohara VV, Ray SS, Chakrabarti P, Utpal C. Chronic myeloid leukemia in children and adolescents: A single center experience from eastern India. South Asian J Cancer 2013;4:260-4.
  • 2 Björkholm M, Ohm L, Eloranta S, Derolf A, Hultcrantz M, Sjöberg J, et al. Success story of targeted therapy in chronic myeloid leukemia: A population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol 2011;29:2514-20.
  • 3 Andolina JR, Neudorf SM, Corey SJ. How I treat childhood CML. Blood 2012;119:1821-30.
  • 4 Champagne MA, Capdeville R, Krailo M, Qu W, Peng B, Rosamilia M, et al. Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: Results from a children′s oncology group phase 1 study. Blood 2004;104:2655-60.
  • 5 Millot F, Baruchel A, Guilhot J, Petit A, Leblanc T, Bertrand Y, et al. Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: Results of the French national phase IV trial. J Clin Oncol 2011;29:2827-32.